Atlas Trials

Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment

Clinical trial NCT03557658 · COMPLETED

Trial details

NCT number
NCT03557658
Sponsor
Theracos
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type2 Diabetes Mellitus
Start date
2018-07-26
Primary completion
2018-12-26
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.